Uncategorised - European Medical Journal

HLTH Europe 2025: Where Vision Meets Action

IT IS with genuine pleasure and a full heart that I reflect on HLTH Europe 2025, an event that did more than bring together healthcare…

Broadening Horizons in Health Innovation: Insights from HLTH Europe 2025

NOW IN its seventh year, HLTH has evolved into a global bellwether for innovation in healthcare. HLTH Europe 2025 convened over 12,000…

Lower eGDR Linked to Higher Gallstone Risk

This study focused on eGDR, a widely accessible proxy for insulin sensitivity derived from waist circumference, hypertension status, and HbA1c levels.

CEUS Outperforms Doppler Ultrasound in RA Synovitis Detection

A recent systematic review and meta-analysis have highlighted the enhanced diagnostic ability of contrast-enhanced ultrasound (CEUS) over traditional Doppler ultrasound (DUS) for identifying active synovitis in patients with rheumatoid arthritis (RA).

Acute Kidney Injury Requiring Dialysis After PCI Signals Poor Prognosis

Dialysis-requiring AKI after PCI remains rare but deadly, with high mortality and complication rates demanding vigilant care.

Chronic Graft-Versus-Host Disease: The Hidden Impact of Cutaneous Ulcers

Cutaneous ulcers present a significant challenge in the management of chronic graft-versus-host disease (cGVHD), a complication that affects patients who have undergone allogeneic hematopoietic cell transplantation.

Rapid DNA Biochip Detects TB Drug Resistance Mutations

A newly developed DNA biochip offers a promising solution for the rapid screening of second-line drug resistance (SLDR) in Mycobacterium tuberculosis, offering faster detection and improved accuracy for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).

Study Highlights Overlap Between GI Burden and Eating Disorders in Systemic Sclerosis

A nationwide Spanish study finds that nearly half of systemic sclerosis patients experience ARFID symptoms, often driven by GI discomfort and fear around eating.

Improved Survival After Stem Cell Transplant from Mismatched Donors

A study shows that patients receiving stem cell transplants from HLA-mismatched unrelated donors can achieve strong survival outcomes with post-transplant cyclophosphamide (PTCy)-based graft-versus-host disease prevention.

The word spotlight on a blue background

Spotlight: July 2025

From concerning statistics on global health outcomes to new insights on AI and RWD, there’s plenty to discover.